Sara A. Hurvitz, MD, FACP, discusses rethinking the routine use of anthracyclines for breast cancer in the modern era. 

Sara A. Hurvitz, MD, FACP, is a medical oncologist, senior vice president, professor in, and director of the Clinical Research Division at Fred Hutchinson Cancer Center in Seattle, Washington. She also serves as the Smith Family Endowed Chair in Women’s Health.

Rethinking Routine Use of Anthracyclines for Breast Cancer in the Modern Era

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.